These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35571028)

  • 1. Molecular Mechanisms of Isolated Polycystic Liver Diseases.
    Yu Z; Shen X; Hu C; Zeng J; Wang A; Chen J
    Front Genet; 2022; 13():846877. PubMed ID: 35571028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated polycystic liver disease genes define effectors of polycystin-1 function.
    Besse W; Dong K; Choi J; Punia S; Fedeles SV; Choi M; Gallagher AR; Huang EB; Gulati A; Knight J; Mane S; Tahvanainen E; Tahvanainen P; Sanna-Cherchi S; Lifton RP; Watnick T; Pei YP; Torres VE; Somlo S
    J Clin Invest; 2017 Sep; 127(9):3558. PubMed ID: 28862642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical manifestation, epidemiology, genetic basis, potential molecular targets, and current treatment of polycystic liver disease.
    Mahboobipour AA; Ala M; Safdari Lord J; Yaghoobi A
    Orphanet J Rare Dis; 2024 Apr; 19(1):175. PubMed ID: 38671465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated polycystic liver disease genes define effectors of polycystin-1 function.
    Besse W; Dong K; Choi J; Punia S; Fedeles SV; Choi M; Gallagher AR; Huang EB; Gulati A; Knight J; Mane S; Tahvanainen E; Tahvanainen P; Sanna-Cherchi S; Lifton RP; Watnick T; Pei YP; Torres VE; Somlo S
    J Clin Invest; 2017 May; 127(5):1772-1785. PubMed ID: 28375157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling polycystic liver disease progression using age-adjusted liver volumes and targeted mutational analysis.
    Sierks D; Schönauer R; Friedrich A; Hantmann E; de Fallois J; Linder N; Fischer J; Herber A; Bergmann C; Berg T; Halbritter J
    JHEP Rep; 2022 Nov; 4(11):100579. PubMed ID: 36246085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management.
    Cnossen WR; Drenth JP
    Orphanet J Rare Dis; 2014 May; 9():69. PubMed ID: 24886261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in GANAB, Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease.
    Porath B; Gainullin VG; Cornec-Le Gall E; Dillinger EK; Heyer CM; Hopp K; Edwards ME; Madsen CD; Mauritz SR; Banks CJ; Baheti S; Reddy B; Herrero JI; Bañales JM; Hogan MC; Tasic V; Watnick TJ; Chapman AB; Vigneau C; Lavainne F; Audrézet MP; Ferec C; Le Meur Y; Torres VE; ; ; Harris PC
    Am J Hum Genet; 2016 Jun; 98(6):1193-1207. PubMed ID: 27259053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy-mediated reduction of miR-345 contributes to hepatic cystogenesis in polycystic liver disease.
    Masyuk T; Masyuk A; Trussoni C; Howard B; Ding J; Huang B; LaRusso N
    JHEP Rep; 2021 Oct; 3(5):100345. PubMed ID: 34568801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases.
    Cornec-Le Gall E; Torres VE; Harris PC
    J Am Soc Nephrol; 2018 Jan; 29(1):13-23. PubMed ID: 29038287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Analysis of Severe Polycystic Liver Disease in Japan.
    Mizuno H; Besse W; Sekine A; Long KT; Kurihara S; Oba Y; Yamanouchi M; Hasegawa E; Suwabe T; Sawa N; Ubara Y; Somlo S; Hoshino J
    Kidney360; 2024 May; ():. PubMed ID: 38689396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive mutational analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease.
    Waanders E; te Morsche RH; de Man RA; Jansen JB; Drenth JP
    Hum Mutat; 2006 Aug; 27(8):830. PubMed ID: 16835903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease.
    Hoevenaren IA; Wester R; Schrier RW; McFann K; Doctor RB; Drenth JP; Everson GT
    Liver Int; 2008 Feb; 28(2):264-70. PubMed ID: 17927714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic Kidney/Liver Disease.
    Roediger R; Dieterich D; Chanumolu P; Deshpande P
    Clin Liver Dis; 2022 May; 26(2):229-243. PubMed ID: 35487607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex, Genotype, and Liver Volume Progression as Risk of Hospitalization Determinants in Autosomal Dominant Polycystic Liver Disease.
    Schönauer R; Sierks D; Boerrigter M; Jawaid T; Caroff L; Audrezet MP; Friedrich A; Shaw M; Degenhardt J; Forberger M; de Fallois J; Bläker H; Bergmann C; Gödiker J; Schindler P; Schlevogt B; Müller RU; Berg T; Patterson I; Griffiths WJ; Sayer JA; ; Popp B; Torres VE; Hogan MC; Somlo S; Watnick TJ; Nevens F; Besse W; Cornec-Le Gall E; Harris PC; Drenth JPH; Halbritter J
    Gastroenterology; 2024 May; 166(5):902-914. PubMed ID: 38101549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-exome sequencing reveals LRP5 mutations and canonical Wnt signaling associated with hepatic cystogenesis.
    Cnossen WR; te Morsche RH; Hoischen A; Gilissen C; Chrispijn M; Venselaar H; Mehdi S; Bergmann C; Veltman JA; Drenth JP
    Proc Natl Acad Sci U S A; 2014 Apr; 111(14):5343-8. PubMed ID: 24706814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal hepatocystin caused by truncating PRKCSH mutations leads to autosomal dominant polycystic liver disease.
    Drenth JP; Tahvanainen E; te Morsche RH; Tahvanainen P; Kääriäinen H; Höckerstedt K; van de Kamp JM; Breuning MH; Jansen JB
    Hepatology; 2004 Apr; 39(4):924-31. PubMed ID: 15057895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Longitudinal Study of Liver Cysts in Patients With Autosomal Dominant Polycystic Kidney Disease and Polycystic Liver Disease.
    Matsuura R; Honda K; Hamasaki Y; Doi K; Noiri E; Nangaku M
    Kidney Int Rep; 2017 Jan; 2(1):60-65. PubMed ID: 29142941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of polycystic liver diseases.
    Lee-Law PY; van de Laarschot LFM; Banales JM; Drenth JPH
    Curr Opin Gastroenterol; 2019 Mar; 35(2):65-72. PubMed ID: 30652979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity is present in SEC63 germline carriers with polycystic liver disease.
    Janssen MJ; Salomon J; Te Morsche RH; Drenth JP
    PLoS One; 2012; 7(11):e50324. PubMed ID: 23209713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver cyst gene knockout in cholangiocytes inhibits cilium formation and Wnt signaling.
    Wills ES; Te Morsche RHM; van Reeuwijk J; Horn N; Geomini I; van de Laarschot LFM; Mans DA; Ueffing M; Boldt K; Drenth JPH; Roepman R
    Hum Mol Genet; 2017 Nov; 26(21):4190-4202. PubMed ID: 28973524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.